MedPath
NMPA Approval

Compound Aminophenazone and Barbital Injection

国药准字H41025443

September 5, 2019

Drug Information

复方氨林巴比妥注射液

注射剂

2ml:氨基比林0.1g,安替比林40mg,巴比妥18mg

化学药品

September 5, 2019

Company Information

Applicant Company

Manufacturing Company

新郑市人民路北侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨林巴比妥注射液 - NMPA 批准文号 | MedPath